MBX Biosciences Inc
NASDAQ:MBX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MBX Biosciences Inc
NASDAQ:MBX
|
US |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for MBX Biosciences Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What MBX Biosciences Does
MBX Biosciences is a biopharmaceutical company that develops peptide-based medicines for diseases tied to hormone regulation and metabolism. Its main focus is on designing longer-acting therapies that can be taken less often than older peptide drugs, using its drug-discovery platform to improve how these medicines behave in the body. The company does not sell a broad lineup of commercial drugs; it is still mainly an R&D-stage business built around advancing a small number of product candidates.
- Headquarters
- United States of America US
- Employees
- 63
- IPO date
- Sep 13, 2024